Microbot Medical Inc. (MBOT) has been beaten down lately with too much selling pressure. While the stock has lost 28.2% over the past four weeks, there is light at the end of the tunnel as it is now ...
Microbot Medical is transitioning from R&D to commercialization with its LIBERTY single-use robotic system for endovascular interventions. I assign MBOT a neutral rating with a 1-year price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results